Ac-225-DOTA-SP
225Ac-DOTA-SP (225Ac-Substance-P) is developed as local treatment for glioblastoma and [...]
225Ac-DOTA-SP (225Ac-Substance-P) is developed as local treatment for glioblastoma and [...]
186Re-RNL (186Re-Rhenium Nano Liposome) is a non-specific locally irradiating drug [...]
rhPSMA (radiohybrid PSMA) is a prostate specific membrane antigen labeled [...]
90Y-BetaGlue is an original product described as a medical device [...]
90Y-Anditixafortide (90Y-Pentixather) is the therapeutic analogue of 68Ga-Pentixafor, to be [...]
TLX101 (formerly ACD-101) is a small molecule (4-Iodophenylalanine), radioactively labeled [...]
117mSn-DOTA-Annexin V is a natural protein labeled with Tin-117m that [...]
177Lu-DOTAZOL is a drug suitable for betatherapy of bone metastases [...]
177Lu-Rosopatamab (177Lu-J591, 177Lu-TLX591, 177Lu-J591, 177Lu-ATL-101) is the Lutetium-177 labeled [...]
177Lu-Pentixather is the therapeutic analogue of 68Ga-Pentixafor, to be used [...]